Aldo-keto reductases 1B in endocrinology and metabolism

46Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

The aldose reductase (AR; human AKR1B1/mouse Akr1b3) has been the focus of many research because of its role in diabetic complications. The starting point of these alterations is the massive entry of glucose in polyol pathway where it is converted into sorbitol by this enzyme. However, the issue of AR function in non-diabetic condition remains unresolved. AR-like enzymes (AKR1B10, Akr1b7, and Akr1b8) are highly related isoforms often co-expressed with bona fide AR, making functional analysis of one or the other isoform a challenging task. AKR1B/Akr1b members share at least 65% protein identity and the general ability to reduce many redundant substrates such as aldehydes provided from lipid peroxidation, steroids and their by-products, and xenobiotics in vitro. Based on these properties, AKR1B/Akr1b are generally considered as detoxifying enzymes. Considering that divergences should be more informative than similarities to help understanding their physiological functions, we chose to review specific hallmarks of each human/mouse isoforms by focusing on tissue distribution and specific mechanisms of gene regulation. Indeed, although the AR shows ubiquitous expression, AR-like proteins exhibit tissue-specific patterns of expression. We focused on three organs where certain isoforms are enriched, the adrenal gland, enterohepatic, and adipose tissues and tried to connect recent enzymatic and regulation data with endocrine and metabolic functions of these organs. We presented recent mouse models showing unsuspected physiological functions in the regulation of glucido-lipidic metabolism and adipose tissue homeostasis. Beyond the widely accepted idea that AKR1B/Akr1b are detoxification enzymes, these recent reports provide growing evidences that they are able to modify or generate signal molecules. This conceptually shifts this class of enzymes from unenviable status of scavenger to upper class of messengers. © 2012 Pastel, Pointud, Volat, Martinez and Lefrançois-Martinez.

References Powered by Scopus

Biochemistry and molecular cell biology of diabetic complications

7630Citations
N/AReaders
Get full text

SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver

4246Citations
N/AReaders
Get full text

Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor

3258Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls

126Citations
N/AReaders
Get full text

Physiological and pathological roles of aldose reductase

85Citations
N/AReaders
Get full text

Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system

84Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Pastel, E., Pointud, J. C., Volat, F., Martinez, A., & Lefrançois-Martinez, A. M. (2012). Aldo-keto reductases 1B in endocrinology and metabolism. Frontiers in Pharmacology, 3 AUG. https://doi.org/10.3389/fphar.2012.00148

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

66%

Researcher 12

24%

Professor / Associate Prof. 4

8%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 26

54%

Biochemistry, Genetics and Molecular Bi... 14

29%

Medicine and Dentistry 5

10%

Pharmacology, Toxicology and Pharmaceut... 3

6%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 18

Save time finding and organizing research with Mendeley

Sign up for free